Barbara A Hendrickson (Barbara Hendrickson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Top Venues

Therapeutic innovation & regulatory science

Journal of biopharmaceutical statistics

Pharmaceutical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara A Hendrickson, Cynthia McShea, Greg Ball, Susan Talbot
How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions. Therapeutic innovation & regulatory science (2024)
Barbara A Hendrickson, Cynthia McShea, Greg Ball, Susan Talbot
How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions. Therapeutic innovation & regulatory science 58 (4) (2024)
Barbara A Hendrickson, Anupam Agarwal, Dimitri Bennett, Jürgen Kübler, Cynthia McShea, Lothar Tremmel
Value and Implementation of the Aggregate Safety Assessment Plan. Pharmaceutical medicine (2023)
James Buchanan, Mengchun Li, Barbara A Hendrickson, Parul Bhargava, Satrajit Roychoudhury
Assessing adverse events in clinical trials during the era of the COVID-19 pandemic. Journal of biopharmaceutical statistics (2023)
Barbara A Hendrickson, William Wang, Greg Ball, Dimitri Bennett, Amit Bhattacharyya, Michael Fries, Juergen Kuebler, Raffael Kurek, Cynthia McShea, Lothar Tremmel
Aggregate Safety Assessment Planning for the Drug Development Life-Cycle. Therapeutic innovation & regulatory science 55 (4) (2021)